Sensory and thermal quantitative testing in children with sickle cell disease

Journal of Pediatric Hematology/Oncology

Volumn 37, Issue 3, 2015, Pages 185-189

  Jacob, Eufemia ^a   Chan, Victoria Wong ^a   Hodge, Christopher ^a   Zeltzer, Lonnie ^b,c   Zurakowski, David ^d   Sethna, Navil F ^d,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Pediatric Pain and Comfort Care Program   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e Department of Anesthesia Perioperative and Pain Medicine Mayo Family Pediatric Pain Rehabilitation Center   (United States)

Author keywords

Children; neuropathic pain; quantitative sensory testing; sickle cell disease

Indexed keywords

ABNORMAL SENSATION; ADOLESCENT; ALLODYNIA; ANALYTIC METHOD; ARTICLE; AWARENESS; BLOOD VESSEL OCCLUSION; BRAIN FUNCTION; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; COLD SENSATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FUNCTIONAL ASSESSMENT; HEAT SENSATION; HUMAN; HYPESTHESIA; MALE; NEUROPATHIC PAIN; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; PROFESSIONAL KNOWLEDGE; PSYCHOLOGIC TEST; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; QUANTITATIVE SENSORY TESTING; REVISED CHILD ANXIETY AND DEPRESSION SCALE; SCHOOL CHILD; SENSITIVITY ANALYSIS; SICKLE CELL ANEMIA; STIMULUS RESPONSE; CASE CONTROL STUDY; COLD; COMPARATIVE STUDY; COMPLICATION; FOLLOW UP; HEAT; MECHANICAL STRESS; PAIN; PAIN THRESHOLD; PATHOLOGY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SENSATION DISORDERS;

ADOLESCENT; ANEMIA, SICKLE CELL; CASE-CONTROL STUDIES; CHILD; COLD TEMPERATURE; FEMALE; FOLLOW-UP STUDIES; HOT TEMPERATURE; HUMANS; MALE; PAIN; PAIN THRESHOLD; PROGNOSIS; SENSATION DISORDERS; STRESS, MECHANICAL;

EID: 84926406670     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0000000000000214     Document Type: Article

References (40)

1. Okpala I, Tawil A. Management of pain in sickle-cell disease. J R Soc Med. 2002;95:456-458.
2. Ballas SK, Lusardi M. Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance. Am J Hematol. 2005;79:17-25.
3. Ballas SK, Kesen MR, Goldberg MF, et al. Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management. Scientific World Journal. 2012;2012:949535.
4. Dampier C, Ely E, Brodecki D, et al. Home management of pain in sickle cell disease: a daily diary study in children and adolescents. J Pediatr Hematol Oncol. 2002;24:643-647.
5. Ballas SK, Gupta K, Adams-Graves P. Sickle cell pain: a critical reappraisal. Blood. 2012;120:3647-3656.
6. Meier P, Berde C, DiCanzio J, et al. Quantitative assessment of cutaneous thermal and vibration sensation and thermal pain detection thresholds in healthy children and adolescents. Muscle Nerve. 2001;24:1339-1345.
7. Tesler MD, Savedra MC, Holzemer WL, et al. The word-graphic rating scale as a measure of children's and adolescents' pain intensity. Res Nurs Health. 1991;14:361-371.
8. Chorpita BF, Moffitt CE, Gray J. Psychometric properties of the Revised Child Anxiety and Depression Scale in a clinical sample. Behav Res Ther. 2005;43:309-322.
9. Varni JW, Burwinkle TM, Seid M, et al. The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr. 2003;3:329-341.
10. Savedra MC, Holzemer WL, Tesler MD, Wilkie DJ. Assessment of postoperation pain in children and adolescents using the adolescent pediatric pain tool. Nurs Res. 1993;42:5-9.
11. Jacob E, Stinson J, Duran J, Gupta A, Gerla M, Ann Lewis M, Zeltzer L. Usability testing of a Smartphone for accessing a web-based e-diary for self-monitoring of pain and symptoms in sickle cell disease. J Pediatr Hematol Oncol. 2012;34:326-35.
12. Nebor D, Bowers A, Hardy-Dessources MD, et al. Frequency of pain crises in sickle cell anemia and its relationship with the sympatho-vagal balance, blood viscosity and inflammation. Haematologic. 2011;96:1589-1594.
13. Clarke MC, Chow CS, Chase JW, et al. Quality of life in children with slow transit constipation. J Pediatr Surg. 2008;43:320-324.
14. Goldstein SL, Graham N, Burwinkle T, et al. Health-related quality of life in pediatric patients with ESRD. Pediatr Nephrol. 2006;21:846-850.
15. Hughes AR, Farewell K, Harris D, et al. Quality of life in a clinical sample of obese children. Int J Obes (Lond). 2007;31:39-44.
16. Marcus SB, Strople JA, Neighbors K, et al. Fatigue and health-related quality of life in pediatric inflammatory bowel disease. Clin Gastroenterol Hepatol. 2009;7:554-561.
17. McKenna AM, Keating LE, Vigneux A, et al. Quality of life in children with chronic kidney disease-patient and caregiver assessments. Nephrol Dial Transplant. 2006;21:1899-1905.
18. Penn A, Lowis SP, Hunt LP, et al. Health related quality of life in the first year after diagnosis in children with brain tumours compared with matched healthy controls; a prospective longitudinal study. Eur J Cancer. 2008;44:1243-1252.
19. Riazi A, Shakoor S, Dundas I, et al. Health-related quality of life in a clinical sample of obese children and adolescents. Health Qual Life Outcomes. 2010;8:134.
20. Walker SM. Biological and neurodevelopmental implications of neonatal pain. Clin Perinatol. 2013;40:471-491.
21. Wollgarten-Hadamek I, Hohmeister J, Demirakca S, et al. Do burn injuries during infancy affect pain and sensory sensitivity in later childhood? Pain. 2009;141:165-172.
22. Cain DM, Vang D, Simone DA, et al. Mouse models for studying pain in sickle disease: effects of strain, age, and acuteness. Br J Haematol. 2012;156:535-544.
23. Brandow AM, Stucky CL, Hillery CA, et al. Patients with sickle cell disease have increased sensitivity to cold and heat. Am J Hematol. 2013;88:37-43.
24. O'Leary JD, Crawford MW, Odame I, et al. Thermal pain and sensory processing in children with sickle cell disease. Clin J Pain. 2014;30:244-250.
25. Yarnitsky D. Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): its relevance for acute and chronic pain states. Curr Opin Anaesthesiol. 2010;23: 611-615.
26. Garrison SR, Kramer AA, Gerges NZ, et al. Sickle cell mice exhibit mechanical allodynia and enhanced responsiveness in light touch cutaneous mechanoreceptors. Mol Pain. 2012;8: 62.
27. Kohli DR, Li Y, Khasabov SG, et al. Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids. Blood. 2010;116: 456-465.
28. Hillery CA, Kerstein PC, Vilceanu D, et al. Transient receptor potential vanilloid 1 mediates pain in mice with severe sickle cell disease. Blood. 2011;118:3376-3383.
29. Rolke R, Baron R, Maier C, et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain. 2006;123:231-243.
30. Dworkin RH, O'Connor AB, Backonja M, et al. Pharmaco-logic management of neuropathic pain: evidence-based recommendations. Pain. 2007;132:237-251.
31. Carstensen M, Møller AM. Adding ketamine to morphine for intravenous patient-controlled analgesia for acute postoperative pain: a qualitative review of randomized trials. Br J Anaesth. 2010;104:401-406.
32. Uprety D, Baber A, Foy M. Ketamine infusion for sickle cell pain crisis refractory to opioids: a case report and review of literature. Ann Hematol. 2014;93:769-771.
33. Tawfic QA, Faris AS, Eipe N. Sickle cell pain management: are we missing the role of pronociception and neuropathic pain? Paediatr Anaesth. 2013;23:1104-1105.
34. Tawfic QA, Faris AS, Kausalya R. The role of a low-dose ketamine-midazolam regimen in the management of severe painful crisis in patients with sickle cell disease. J Pain Symptom Manage. 2014;47:334-340.
35. Jennings CA, Bobb BT, Noreika DM, et al. Oral ketamine for sickle cell crisis pain refractory to opioids. J Pain Palliat Care Pharmacother. 2013;27:150-154.
36. Neri CM, Pestieau SR, Darbari DS. Low-dose ketamine as a potential adjuvant therapy for painful vaso-occlusive crises in sickle cell disease. Paediatr Anaesth. 2013;23:684-689.
37. Meals CG, Mullican BD, Shaffer CM, et al. Ketamine infusion for sickle cell crisis pain in an adult. J Pain Symptom Manage. 2011;42:e7-e9.
38. Zempsky WT, Loiselle KA, Corsi JM, et al. Use of low-dose ketamine infusion for pediatric patients with sickle cell disease-related pain: a case series. Clin J Pain. 2010;26: 163-167.
39. Wang ZJ, Wilkie DJ, Molokie R. Neurobiological mechanisms of pain in sickle cell disease. Hematology Am Soc Hematol Educ Program. 2010;2010:403-408.
40. Switzer JA, Hess DC, Nichols FT, et al. Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Lancet Neurol. 2006;5:501-512.